Drug · DIN 01926853
FLAGYL
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since May 15, 2024; first marketed December 31, 1979.
- Drug Identification Number (DIN)
- 01926853
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Metronidazole P01AB01
- Class
- Human
- Record last updated
- May 14, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| METRONIDAZOLE | 500 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 24, 2023: NOC 30841New Drug Submission (NDS) · Administrative: Change in Product Ownership
- July 6, 2017: NOC 19496New Drug Submission (NDS) · Transfer of drug identification number
- March 29, 2006: NOC 7844New Drug Submission (NDS) · Manufacturer name change
- October 27, 2000: NOC 1284New Drug Submission (NDS)
Other DINs named FLAGYL
- DIN 01926861 · Cancelled Post Market